Literature DB >> 2926813

Nuclear factor I can functionally replace transcription factor Sp1 in a U2 small nuclear RNA gene enhancer.

L Janson1, P Weller, U Pettersson.   

Abstract

Polymerase II transcription of a human gene for the small nuclear RNA U2 is dependent on two different promoter elements: a TATA-equivalent proximal sequence element and a distal enhancer element, which has been shown to contain Sp1- and octamer-binding sites. We have investigated the functional interplay between these transcription factor-binding sites of the enhancer, following transfection of U2 maxigene constructions into HeLa cells. There is a functional non-additive co-operation between the octamer-binding factor and Sp1, which is not dependent on the evolutionally conserved steric arrangement of these binding sites. We demonstrate that the conserved Sp1-binding site of the U2 enhancer can be fully substituted by a nuclear factor I (NFI) binding site, and that the octamer-binding factor functions in stimulating transcription in conjunction with either Sp1 or NFI. Since the octamer-binding factor is most probably the same protein as nuclear factor III (NFIII), the results imply that the NFI/NFIII complex, involved in adenovirus DNA replication, also can function as an efficient activator of transcription.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926813     DOI: 10.1016/0022-2836(89)90349-5

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  Cooperative interactions between transcription factors Sp1 and OTF-1.

Authors:  L Janson; U Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression.

Authors:  A C Ström; M Forsberg; P Lillhager; G Westin
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

3.  Molecular and functional characterization of the promoter region of the mouse LDH/C gene: enhancer-assisted, Sp1-mediated transcriptional activation.

Authors:  J Yang; K Thomas
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

4.  Differential in vivo activation of the class II and class III snRNA genes by the POU-specific domain of Oct-1.

Authors:  S Murphy
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

5.  Cooperation between CCAAT and octamer motifs in the distal sequence element of the rat U3 small nucleolar RNA promoter.

Authors:  R A Ach; A M Weiner
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

6.  The transcriptionally competent U2 gene is necessary and sufficient for adenovirus type 12 induction of the fragile site at 17q21-22.

Authors:  S Gargano; P Wang; E Rusanganwa; S Bacchetti
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

7.  Both Oct-1 and Oct-2A contain domains which can activate the ubiquitously expressed U2 snRNA genes.

Authors:  J Yang; M M Müller-Immerglück; K Seipel; L Janson; G Westin; W Schaffner; U Pettersson
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

8.  Different N-terminal isoforms of Oct-1 control expression of distinct sets of genes and their high levels in Namalwa Burkitt's lymphoma cells affect a wide range of cellular processes.

Authors:  Elizaveta V Pankratova; Alexander G Stepchenko; Tatiana Portseva; Vladic A Mogila; Sofia G Georgieva
Journal:  Nucleic Acids Res       Date:  2016-07-12       Impact factor: 16.971

9.  GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.

Authors:  Simon Fishilevich; Ron Nudel; Noa Rappaport; Rotem Hadar; Inbar Plaschkes; Tsippi Iny Stein; Naomi Rosen; Asher Kohn; Michal Twik; Marilyn Safran; Doron Lancet; Dana Cohen
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

Review 10.  Regulation of expression of human RNA polymerase II-transcribed snRNA genes.

Authors:  Joana Guiro; Shona Murphy
Journal:  Open Biol       Date:  2017-06       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.